Related references
Note: Only part of the references are listed.Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors
Gang Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers
Gurushankar Chandramouly et al.
CHEMISTRY & BIOLOGY (2015)
Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation
Paulina Podszywalow-Bartnicka et al.
CELL CYCLE (2014)
Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease
Theresa Tiefenbrunn et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response
Michael Tallis et al.
CHROMOSOMA (2014)
Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery
Markus O. Zimmermann et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile
Kimberly Cramer-Morales et al.
BLOOD (2013)
Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53
Rainer Wilcken et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Quantitative Live Cell Imaging Reveals a Gradual Shift between DNA Repair Mechanisms and a Maximal Use of HR in Mid S Phase
Ketki Karanam et al.
MOLECULAR CELL (2012)
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
Elisabet Wahlberg et al.
NATURE BIOTECHNOLOGY (2012)
Antileukemic effects of AMPK activators on BCR-ABL-expressing cells
Eliza Vakana et al.
BLOOD (2011)
Poly(ADP-Ribose) Polymerase (PARP) Inhibitors: Exploiting a Synthetic Lethal Strategy in the Clinic
Timothy A. Yap et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Rad52 inactivation is synthetically lethal with BRCA2 deficiency
Zhihui Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Automated Docking Screens: A Feasibility Study
John J. Irwin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Identification of a second DNA binding site in the human Rad52 protein
Wataru Kagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
DNA repair pathways as targets for cancer therapy
Thomas Helleday et al.
NATURE REVIEWS CANCER (2008)
Structure-based discovery of inhibitors of the YycG histidine kinase:: New chemical leads to combat Staphylococcus epidermidis infections
Zhiqiang Qin et al.
BMC MICROBIOLOGY (2006)
Peptide aptamers as guides for small-molecule drug discovery
IC Baines et al.
DRUG DISCOVERY TODAY (2006)
Genetic steps of mammalian homologous repair with distinct mutagenic consequences
JM Stark et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Structure of the single-strand annealing domain of human RAD52 protein
MR Singleton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Crystal structure of the homologous-pairing domain from the human Rad52 recombinase in the undecameric form
W Kagawa et al.
MOLECULAR CELL (2002)
Double-strand breaks and translocations in cancer
B Elliott et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Share Paper
